Search results
Vivien Marasigan's 8 research works with 28 citations and 290 reads, including: Determinants of 25-hydroxyvitamin D Status in a Cutaneous Melanoma Population
Abstract. The rising incidence of cutaneous melanoma and its stable high mortality rates despite innovative cancer care, require better prediction of the clinical outcome.
Vivien Marasigan, Canan Güvenç, Joost J. van den Oord, Marguerite Stas, Veerle Boecxstaens, Oliver Bechter, Pascal Wolter, Diether Lambrechts, Marjan Garmyn. DOI: 10.2340/00015555-3270. Abstract.
Sep 17, 2015 · Background. Atopic dermatitis (AD) has been linked to fewer nevi which implies a decreased risk for melanoma. Yet scarce studies have been conducted on the association between AD and melanoma. Go to: Aim. To analyze the association of AD and melanoma development in a case-control population. Go to: Methods.
- Vivien Marasigan, Marie-Anne Morren, Julien Lambert, Karen Medaer, Steffen Fieuws, Marjan Garmyn
- 2015
Jul 1, 2020 · Cardiovascular diseases, and acute coronary syndrome (ACS), among others, are important causes of morbidity and mortality in Brazil and across the world (World Health Organization, 2014; Piegas et al., 2015; Marasigan et al., 2020).
- Vivien Marasigan, Vivien Marasigan, Vivien Marasigan, Ivan Perry, Kathleen Bennett, Kevin Balanda, S...
- 2020
Vivien Marasigan, Marie-Anne Morren, Julien Lambert, Karen Medaer, Steffen Fieuws, Tamar Nijsten, Marjan Garmyn. DOI: 10.2340/00015555-2476. Abstract. Heightened cutaneous immune surveillance in atopic patients may inhibit development of melanoma.
Abstract. Vitamin D status is influenced by well-known determinants, but factors associated with low 25-hydroxyvitamin D levels in the cutaneous melanoma population are not well defined. The aim of this study was to confirm the well-known determinants and to assess new determinants for 25-hydroxyvitamin D levels in a cutaneous melanoma population.
